Our study aimed to assess the consequences of BZ resistance-associated mutations on the in silico dimerization of hookworm tubulin α and β subunits. Using A. ceylanicum as the model organism, the folding and interaction of the tubulin heterodimers were predicted using AlphaFold 3. Folding predictions were considered accurate and reliable based on several quality assurance checks. Assessment of the dimer’s interactions showed that the introduction of resistance-associated mutations into the β tubulin altered the binding properties of the dimer. Likewise, the mutations also modified the amino acids interacting in the α and β subunits and their corresponding binding free energies. However, molecular dynamics simulations of atomic flexibility and motions revealed that both wildtype and mutated heterodimers had comparable structural flexibility and mobility. To our knowledge, this is the first study on in silico dimerization of hookworm tubulins concerning benzimidazole resistance. These results provide several implications for the study of benzimidazole resistance in hookworms.
Our in silico dimerization of wild-type and mutated hookworm tubulins revealed several changes in dimer interactions due to the addition of the benzimidazole resistance-associated amino acid substitutions in the β subunit. E198K, E198V, and F200Y mutations increased the dimer binding energies. A higher binding energy (i.e., higher ΔG_bind and ΔG, lower K_d) between the mutated α- and β-tubulin suggests a stronger interaction between these subunits. This finding is corroborated by previous reports indicating that certain mutations in the α- and β-tubulin improve the stiffness, rupture force, and interface interaction energy of the formed dimer [46]. If the mutated β-tubulin binds more tightly to its α counterpart, the benzimidazole molecule might have difficulty binding to its target site on the β subunit [47]. This is perhaps exemplified by our results showing reduced binding pocket volume in β tubulins with resistance-associated mutations. Moreover, stronger interactions between the subunits can prevent the curving of tubulin conformation observed in crystal structures bound to colchicine [48]. Therefore, the heightening of tubulin subunit binding could assist in conferring benzimidazole resistance. This notion is supported by laboratory studies indicating that E198V, E198K, F167Y, and F200Y conferred marked resistance in C. elegans against Fenbendazole and Albendazole [28]. Furthermore, in silico docking studies have shown that mutated tubulins having amino acid shifts at position 198 had reduced binding affinities with benzimidazoles in Trichuris trichuria, Ancylostoma duodenale, Ascaris lumbricoides, and Haemonchus contortus [18, 30, 49]. Therefore, benzimidazole resistance-associated mutations enhance the hookworm's capacity to resist treatment through strengthening and stabilizing tubulin dimer interactions, beyond hindering benzimidazole binding to the β-tubulin subunit.
On the other hand, Q134H and F200L lowered the binding energies of the predicted tubulin dimer. Lowered binding energies indicate a weaker interaction between the mutated β- and wild-type α-tubulin. Therefore, other mutations could result in a less favorable microtubule structure prone to disassembly and thus detrimental to the hookworm [50, 51]. This notion is perhaps shown by laboratory studies showing that the acquisition of resistance phenotype due to these mutations in helminths is at the cost of survivability [23, 29]. Potential alterations in tubulin heterodimer binding dynamics due to resistance-associated mutations have also been reported by other studies concerned with anticancer drugs. Natarajan and Senapati [52] reported that T237I, R282Q, and Q292E mutations in mammalian β-tubulin can modulate tubulin dimerization through allosteric changes in the N-domain, which is involved in microtubule assembly. Moreover, mutations in the α-tubulin (e.g., W407X, G43V, T145P, and A383T) resulted in reduced hydrogen bonding with its β counterpart and significant departures of RMSD and RMSF values thereby causing tubulin heterocomplex instability [53]. These results, together with ours, indicate that mutations in either β- or α-tubulin subunits confer binding alterations that have consequences on tubulin dimer formation and the subsequent microtubule assembly, which either can assist in drug resistance or be detrimental to the parasite.
Recent advancements in protein folding predictions and protein-protein interaction modeling are a welcome development for anthelmintic resistance studies, particularly those involving benzimidazoles. Through deep learning algorithms trained on data from protein databases, AlphaFold 3 was able to reliably and accurately predict the dimerization of hookworm α- and β-tubulins. It is important to note that the crystal structure of hookworm α-and β-tubulin subunits and their dimerized conformation has yet to be elucidated by crystallography or spectroscopy. However, our structural alignment comparison with the ascertained mammalian tubulin crystal structure showed that our fold predictions from hookworm sequences bore a very close structural resemblance. This finding is also backed by the results of our external quality assurance checks. The lack of available ascertained tubulin crystal structures among soil-transmitted helminths has hampered the study of benzimidazole resistance, which should be addressed urgently. Also, the capacity to conduct in silico dimerization of hookworm tubulins with relative ease provides additional insights into previously reported β tubulin-benzimidazole docking studies [18, 30, 49]. However, our dimerization model does not include the docked benzimidazole ligand as the AlphaFold 3 server cannot incorporate such molecules in its predictions as of writing [54]. Hence, future in silico studies like ours should consider the dimerization of hookworm tubulins with the bound benzimidazole ligand to gain more insights regarding the tubulin disruption action of the drug. However, our research does highlight the use of open-source platforms in the in silico study of drug resistance. Our research presents a free pipeline that applies to those who do not have access to high-end computers and costly software.